These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37728077)

  • 1. Should we be screening for COPD? - looking through the lens of lung cancer screening.
    Young RP; Scott RJ
    Expert Rev Respir Med; 2023; 17(9):753-771. PubMed ID: 37728077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, symptom burden and under-diagnosis of chronic obstructive pulmonary disease in Polish lung cancer screening population: a cohort observational study.
    Undrunas A; Kasprzyk P; Rajca A; Kuziemski K; Rzyman W; Zdrojewski T
    BMJ Open; 2022 Apr; 12(4):e055007. PubMed ID: 35410926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and Characteristics of Individuals with Preserved Ratio Impaired Spirometry (PRISm) and/or Impaired Lung Function in Japan: The OCEAN Study.
    Kaise T; Sakihara E; Tamaki K; Miyata H; Hirahara N; Kirichek O; Tawara R; Akiyama S; Katsumata M; Haruya M; Ishii T; Simard EP; Miller BE; Tal-Singer R
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2665-2675. PubMed ID: 34588775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced Expiratory Flow Rate among Heavy Smokers Increases Lung Cancer Risk. Results from the National Lung Screening Trial-American College of Radiology Imaging Network Cohort.
    Hopkins RJ; Duan F; Chiles C; Greco EM; Gamble GD; Aberle D; Young RP
    Ann Am Thorac Soc; 2017 Mar; 14(3):392-402. PubMed ID: 28076701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of COPD in the SUMMIT Study lung cancer screening cohort using symptoms and spirometry.
    Tisi S; Dickson JL; Horst C; Quaife SL; Hall H; Verghese P; Gyertson K; Bowyer V; Levermore C; Mullin AM; Teague J; Farrelly L; Nair A; Devaraj A; Hackshaw A; ; Hurst JR; Janes SM
    Eur Respir J; 2022 Dec; 60(6):. PubMed ID: 35896207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spirometry performed as part of the Manchester community-based lung cancer screening programme detects a high prevalence of airflow obstruction in individuals without a prior diagnosis of COPD.
    Balata H; Harvey J; Barber PV; Colligan D; Duerden R; Elton P; Evison M; Greaves M; Howells J; Irion K; Karunaratne D; Mellor S; Newton T; Sawyer R; Sharman A; Smith E; Taylor B; Taylor S; Tonge J; Walsham A; Whittaker J; Vestbo J; Booton R; Crosbie PA
    Thorax; 2020 Aug; 75(8):655-660. PubMed ID: 32444437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of Self-Administered Questionnaires for Identifying Individuals at Risk of COPD in Japan: The OCEAN (Okinawa COPD casE finding AssessmeNt) Study.
    Tamaki K; Sakihara E; Miyata H; Hirahara N; Kirichek O; Tawara R; Akiyama S; Katsumata M; Haruya M; Ishii T; Simard EP; Miller BE; Tal-Singer R; Kaise T
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1771-1782. PubMed ID: 34168439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung function impairment in the German Lung Cancer Screening Intervention Study (LUSI): prevalence, symptoms, and associations with lung cancer risk, tumor histology and all-cause mortality.
    Kaaks R; Christodoulou E; Motsch E; Katzke V; Wielpütz MO; Kauczor HU; Heussel CP; Eichinger M; Delorme S
    Transl Lung Cancer Res; 2022 Sep; 11(9):1896-1911. PubMed ID: 36248328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population.
    Goffin JR; Pond GR; Puksa S; Tremblay A; Johnston M; Goss G; Nicholas G; Martel S; Bhatia R; Liu G; Schmidt H; Atkar-Khattra S; McWilliams A; Tsao MS; Tammemagi MC; Lam S
    BMC Pulm Med; 2020 Nov; 20(1):300. PubMed ID: 33198781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.
    Rossi A; Butorac-Petanjek B; Chilosi M; Cosío BG; Flezar M; Koulouris N; Marin J; Miculinic N; Polese G; Samaržija M; Skrgat S; Vassilakopoulos T; Vukić-Dugac A; Zakynthinos S; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2593-2610. PubMed ID: 28919728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Airflow limitation and mortality during cancer screening in the National Lung Screening Trial: why quantifying airflow limitation matters.
    Young RP; Ward RC; Scott RJ; Gamble GD; Silvestri G
    Thorax; 2023 Jul; 78(7):690-697. PubMed ID: 36456179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence and mortality risks of PRISm and COPD in the United States from NHANES 2007-2012.
    Cadham CJ; Oh H; Han MK; Mannino D; Cook S; Meza R; Levy DT; Sánchez-Romero LM
    Respir Res; 2024 May; 25(1):208. PubMed ID: 38750492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity.
    Harvey BG; Strulovici-Barel Y; Kaner RJ; Sanders A; Vincent TL; Mezey JG; Crystal RG
    Eur Respir J; 2015 Dec; 46(6):1589-1597. PubMed ID: 26541521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging Features of Chronic Bronchitis with Preserved Ratio and Impaired Spirometry (PRISm).
    Wei X; Ding Q; Yu N; Mi J; Ren J; Li J; Xu S; Gao Y; Guo Y
    Lung; 2018 Dec; 196(6):649-658. PubMed ID: 30218155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of chronic obstructive pulmonary disease among smokers aged 45 and up in Israel.
    Stav D; Raz M
    Isr Med Assoc J; 2007 Nov; 9(11):800-2. PubMed ID: 18085037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between the COPD Assessment Test score and airflow limitation in Japan in patients aged over 40 years with a smoking history.
    Yoshimoto D; Nakano Y; Onishi K; Hagan G; Jones P
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1357-63. PubMed ID: 25525353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of airflow limitation on medical check-up in Japanese subjects.
    Omori H; Nonami Y; Mihara S; Marubayashi T; Morimoto Y; Aizawa H
    J UOEH; 2007 Sep; 29(3):209-19. PubMed ID: 17900001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Airflow Limitation and Histology Shift in the National Lung Screening Trial. The NLST-ACRIN Cohort Substudy.
    Young RP; Duan F; Chiles C; Hopkins RJ; Gamble GD; Greco EM; Gatsonis C; Aberle D
    Am J Respir Crit Care Med; 2015 Nov; 192(9):1060-7. PubMed ID: 26199983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of chronic obstructive pulmonary disease among smokers attending primary healthcare clinics in Saudi Arabia.
    Al Ghobain M; Al-Hajjaj MS; Wali SO
    Ann Saudi Med; 2011; 31(2):129-33. PubMed ID: 21403413
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.